Neta Ilan Selected Research

Head and Neck Neoplasms (Head and Neck Cancer)

1/2021	Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression.
2/2012	Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer.
9/2010	Heparanase 2 interacts with heparan sulfate with high affinity and inhibits heparanase activity.
12/2006	Heparanase localization and expression by head and neck cancer: correlation with tumor progression and patient survival.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neta Ilan Research Topics

Disease

105	Neoplasms (Cancer) 05/2024 - 05/2002
71	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2002
37	Inflammation (Inflammations) 05/2024 - 11/2002
23	Carcinoma (Carcinomatosis) 01/2024 - 06/2006
11	Carcinogenesis 02/2024 - 06/2006
8	Breast Neoplasms (Breast Cancer) 03/2024 - 05/2004
8	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 09/2011
6	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 12/2009
5	Glioma (Gliomas) 01/2019 - 11/2003
5	Lymphoma (Lymphomas) 01/2019 - 01/2016
5	Melanoma (Melanoma, Malignant) 10/2018 - 02/2006
4	Fibrosis (Cirrhosis) 04/2021 - 05/2004
4	Head and Neck Neoplasms (Head and Neck Cancer) 01/2021 - 12/2006
3	Adenocarcinoma 01/2023 - 02/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 08/2012
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2012 - 01/2007
2	Urofacial syndrome 05/2024 - 01/2020
2	Malignant Mesothelioma 10/2018 - 01/2004
2	Lung Neoplasms (Lung Cancer) 04/2018 - 09/2008
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 10/2004
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2016 - 02/2008
2	Leukemia 01/2014 - 01/2007
2	Atherosclerosis 06/2013 - 02/2008
2	Myocardial Infarction 06/2013 - 02/2013
2	Diabetic Nephropathies (Diabetic Nephropathy) 08/2012 - 01/2011
2	Colitis 08/2012 - 01/2007
2	Proteinuria 08/2012 - 01/2012
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2024
1	Glomerulonephritis 10/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Virus Diseases (Viral Diseases) 04/2021
1	Thyroid Neoplasms (Thyroid Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Lewis Lung Carcinoma 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2018
1	Mesothelioma 10/2018
1	Pleural Effusion (Pleural Effusions) 10/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2018
1	Acute Kidney Injury (Acute Renal Failure) 05/2017
1	Edema (Dropsy) 01/2017
1	Pancreatitis 01/2017
1	Polyps 01/2017
1	Brain Neoplasms (Brain Tumor) 12/2016

Drug/Important Bio-Agent (IBA)

117	heparanaseIBA 05/2024 - 05/2002
41	Heparitin Sulfate (Heparan Sulfate)IBA 07/2023 - 05/2002
21	Glycoside Hydrolases (Endoglycosidases)IBA 10/2022 - 01/2004
21	EnzymesIBA 01/2022 - 11/2002
13	GlucuronidaseIBA 01/2021 - 05/2004
12	Heparin (Liquaemin)FDA LinkGeneric 01/2024 - 01/2006
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2004
7	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022 - 10/2004
6	Monoclonal AntibodiesIBA 01/2019 - 06/2006
5	Proteoglycans (Proteoglycan)IBA 01/2017 - 10/2010
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2018 - 02/2006
4	Messenger RNA (mRNA)IBA 12/2011 - 02/2006
3	ErbB Receptors (EGF Receptor)IBA 01/2018 - 12/2008
3	Vascular Endothelial Growth Factor CIBA 10/2016 - 12/2008
2	CateninsIBA 02/2024 - 01/2020
2	CeruletideIBA 01/2023 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2021 - 12/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 10/2016
2	CytokinesIBA 01/2020 - 01/2017
2	ImmunosorbentsIBA 10/2018 - 12/2007
2	OligosaccharidesIBA 01/2017 - 08/2012
2	Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA 04/2016 - 01/2016
2	CollagenIBA 04/2016 - 01/2016
2	Neutralizing AntibodiesIBA 01/2016 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2014 - 04/2013
2	Peptides (Polypeptides)IBA 08/2012 - 06/2010
2	Peptide Hydrolases (Proteases)FDA Link 06/2011 - 06/2010
2	Matrix Metalloproteinases (MMPs)IBA 06/2011 - 06/2010
2	Thromboplastin (Tissue Factor)IBA 01/2008 - 01/2007
2	Small Interfering RNA (siRNA)IBA 02/2006 - 01/2006
1	CarcinogensIBA 01/2023
1	cyclophellitolIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 01/2021
1	Keratins (Keratin)IBA 01/2021
1	AMP-Activated Protein KinasesIBA 01/2021
1	Cadherins (E-Cadherin)IBA 01/2020
1	AgarIBA 01/2019
1	LigandsIBA 01/2019
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2019
1	defibrotideIBA 10/2018
1	Thrombin Receptors (Thrombin Receptor)IBA 10/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	VimentinIBA 05/2017
1	Endothelin-1 (Endothelin 1)IBA 05/2017
1	Biomarkers (Surrogate Marker)IBA 05/2017
1	Interleukin-6 (Interleukin 6)IBA 05/2017
1	Fibronectins (Fibronectin)IBA 05/2017
1	Sulfates (Sulfates, Inorganic)IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 12/2016
1	SugarsIBA 12/2016

Therapy/Procedure

18	Therapeutics 05/2024 - 01/2007
5	Drug Therapy (Chemotherapy) 01/2020 - 02/2007
2	Precision Medicine 03/2024 - 01/2018
1	Subcutaneous Injections 11/2020